All
Research
Education
Araştırma
Eğitim
Business
Çözümler
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Oturum Aç
Chapter 20
Pulmonary hypertension, or PH, denotes the resting mean pulmonary arterial pressure of 25 mm Hg or higher. Pulmonary hypertension can be classified into ...
Phosphodiesterase inhibitors treat pulmonary arterial hypertension or PAH by inhibiting the activity of the phosphodiesterase enzyme. Phosphodiesterase 5 ...
Endothelin receptor antagonists or ERAs counteract the effects of endothelins, or ETs, to treat pulmonary arterial hypertension or PAH. ETs are produced ...
Prostacyclin receptor agonists are vital in managing pulmonary arterial hypertension. They mimic prostaglandin I2 and bind to its receptor, IPR, on ...
Receptor tyrosine kinase inhibitors or TKIs and calcium channel blockers or CCBs are used for pulmonary arterial hypertension or PAH treatment. TKIs like ...
Oxygen therapy can enhance the quality of life of patients with pulmonary arterial hypertension or PAH who experience hypoxemia or low oxygen levels. This ...
Cystic fibrosis, or CF, is an autosomal recessive disorder resulting from mutations in the cystic fibrosis transmembrane conductance regulator or CFTR ...
Cystic fibrosis, or CF, is an autosomal genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator or CFTR gene. CF ...
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
JoVE Sitemap
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır